AzTrials
AzTrials

Tracheostomy PatientsNCT07755969

Evaluation of a Specialised Tracheostomy Team for the Management of Patients With a Tracheostomy Cannula in a Belgium General Hospital: A Retrospective Study.

An observational study of Tracheostomy Patients and Multidisciplinary Care Team, run by Vitaz at 1 site in Belgium.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Patients admitted to intensive care units (ICUs) frequently require prolonged mechanical ventilation. Difficulties in weaning from mechanical ventilation represent an important indication for performing a tracheotomy, which involves creating a temporary opening in the trachea into which a cannula is inserted. Read more about this study

Who is it for?
Any age
What is being tested?
The implementation of the specialised multidisciplinary tracheostomy team.
How many people
200 participants
Where
1 siteBelgium
Study dates
1 Aug 2026to 31 Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: This retrospective study will include adult patients aged ≥18 years who were hospitalised between 2010 and 2026 and had a tracheostomy cannula during their hospitalisation. The study population will include patients with a tracheotomy, permanent tracheostomy, or laryngectomy, irrespective of whether care was provided with curative or palliative intent. Both patients admitted to the intensive care unit and those subsequently transferred to inpatient wards will be included. Patients receiving ambulatory care or day hospitalisation will be excluded.

Who may be able to join

  • Hospitalisation between 2010 and 2026 in VITAZ (general hospital, Belgium)
  • Age ≥18 years.
  • Presence of a tracheostomy cannula (tracheotomy, permanent tracheostomy, or laryngectomy).
  • Curative and palliative patients will be included.

Who cannot join

  • Ambulatory care
  • Day hospitalisation

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Lisa Christiaens, MSc contact

+3237606060

brecht.serraes@vitaz.be

Belgium1 site
  • VITAZ

    Sint-Niklaas, Oost-Vlaanderen, 9100

    Brecht Serraes, Doctor, +3237602039, brecht.serraes@vitaz.be

    Brecht Serraes, Doctor

Other trials in Belgium

About this study

Official title: Management of Patients With a Tracheostomy Cannula by a Specialised Team in a Belgium General Hospital: A Retrospective Study

Patients admitted to intensive care units (ICUs) frequently require prolonged mechanical ventilation. Difficulties in weaning from mechanical ventilation represent an important indication for performing a tracheotomy, which involves creating a temporary opening in the trachea into which a cannula is inserted. This procedure is often confused with a tracheostomy, in which a permanent stoma is created.

Tracheotomy offers several clinical benefits, including increased patient comfort, reduced sedation requirements, decreased work of breathing, improved oral hygiene, a lower risk of ventilator-associated pneumonia, and lower mortality. With the increasing use of the percutaneous technique, the procedure is increasingly performed by intensivists. Consequently, the number of patients with a tracheostomy cannula in the ICU is increasing.

Read more

Following clinical stabilisation, these patients are transferred to inpatient wards throughout the hospital according to their underlying pathology. However, nurses working on these wards encounter tracheostomy-related care less frequently, which may include suctioning, wound care, cannula care, and decannulation.

Despite the availability of clinical procedures and protocols, a lack of knowledge, skills, and confidence in providing safe tracheostomy-related care persists. This increases the risk of complications such as cannula obstruction, infection, hypoxaemia, dislodgement, and bleeding. To address this issue, specialised multidisciplinary tracheostomy teams are increasingly being implemented.

The aim of this retrospective study is to answer the following research question: What is the impact of a specialised multidisciplinary tracheostomy team on clinical outcomes in hospitalised patients with a tracheostomy cannula?

Being tested
The implementation of the specialised multidisciplinary tracheostomy team.
Keywords
Multidisciplinary tracheostomy team, Tracheostomy care, Hospitalised patients with a tracheostomy, Retrospective study, Clinical outcomes, Trachea cannula, tracheostomy related care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The implementation of the specialised multidisciplinary tracheostomy team.Other

    The intervention of interest is the implementation of the specialised multidisciplinary tracheostomy team, which provides structured, team-based care for patients with a tracheostomy cannula.

Study groups in NCT07755969
Study groupRoleWhat they receive
Pre-intervention cohort: Before specialised tracheostomy team implementationHospitalised patients with a tracheostomy cannula who received routine clinical care before the establishment and implementation of the specialised multidisciplinary tracheostomy team. This cohort serves as the pre-intervention comparison group.
Post-intervention cohort: After specialised tracheostomy team implementationHospitalised patients with a tracheostomy cannula who received care after the establishment and implementation of the specialised multidisciplinary tracheostomy team.
Receives: Other: The implementation of the specialised multidisciplinary tracheostomy team.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Tracheo(s)tomy-related ICU readmission

    Occurrence of readmission to the intensive care unit due to tracheo(s)tomy cannula-related problems.

    Measured: through study completion, an average of 1 year

  2. Successful decannulation

    Successful decannulation of the tracheo(s)tomy cannula according to predefined criteria derived from the literature. The proportion of patients achieving successful decannulation will be compared between the pre-intervention and post-intervention cohorts.

    Measured: through study completion, an average of 1 year

  3. Tracheo(s)tomy-related complications

    Occurrence of predefined canulla-related complications, including airway obstruction, wound infection, bleeding, ... .

    Measured: through study completion, an average of 1 year

  4. Performance of FEES

    Performance of a fibreoptic endoscopic evaluation of swallowing (FEES) during hospitalisation.

    Measured: through study completion, an average of 1 year

Secondary outcomes (8)
  1. Total hospital length of stay

    From hospital admission until hospital discharge

    Measured: through study completion, an average of 1 year

  2. Use of high-flow oxygen therapy or active humidification

    Use of high-flow oxygen therapy and/or active humidification during hospitalisation.

    Measured: through study completion, an average of 1 year

  3. Time to tracheo(s)tomy

    Number of days from hospital admission to the performance of the tracheo(s)tomy.

    Measured: through study completion, an average of 1 year

  4. Time from ICU admission to transfer to an inpatient ward

    Duration of intensive care unit stay before transfer to an inpatient ward.

    Measured: through study completion, an average of 1 year

  5. Length of ICU stay following canulla-related readmission

    Duration of intensive care unit stay following readmission due to cannula-related problems.

    Measured: through study completion, an average of 1 year

  6. Mortality due to cannulla-related complications

    Occurrence of death attributable to tracheo(s)tomy- or cannula-related complications.

    Measured: through study completion, an average of 1 year

  7. Use of a speaking valve

    Occurrence and use of a speaking valve during hospitalisation.

    Measured: through study completion, an average of 1 year

  8. Responsible medical discipline

    Location and discipline responsible for tracheostomy placement.

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Aug 2026
  2. Study start1 Aug 2026 (estimated)
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07755969
Sponsor's protocol ID
EC26004
Other IDs
EC26004
Status last verified
Aug 2026
First submitted
24 Jul 2026
Last updated
10 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Speed L, Harding KE. Tracheostomy teams reduce total tracheostomy time and increase speaking valve use: a systematic review and meta-analysis. J Crit Care. 2013 Apr;28(2):216.e1-10. doi: 10.1016/j.jcrc.2012.05.005. Epub 2012 Aug 27.

    PubMed 22951017
  • Parker V, Giles M, Shylan G, Austin N, Smith K, Morison J, Archer W. Tracheostomy management in acute care facilities--a matter of teamwork. J Clin Nurs. 2010 May;19(9-10):1275-83. doi: 10.1111/j.1365-2702.2009.03155.x. Epub 2010 Mar 18.

    PubMed 20345835
  • Ninan A, Grubb LM, Brenner MJ, Pandian V. Effectiveness of interprofessional tracheostomy teams: A systematic review. J Clin Nurs. 2023 Oct;32(19-20):6967-6986. doi: 10.1111/jocn.16815. Epub 2023 Jul 3.

    PubMed 37395139
  • Holmes TR, Cumming BD, Sideris AW, Lee JW, Briggs NE, Havas TE. Multidisciplinary Tracheotomy Teams: An Analysis of Patient Outcomes and Resource Allocation. Ear Nose Throat J. 2019 Apr-May;98(4):232-237. doi: 10.1177/0145561319840103. Epub 2019 Apr 2.

    PubMed 30939910
  • Garrubba M, Turner T, Grieveson C. Multidisciplinary care for tracheostomy patients: a systematic review. Crit Care. 2009;13(6):R177. doi: 10.1186/cc8159. Epub 2009 Nov 6.

    PubMed 19895690
  • Brenner MJ, Pandian V, Milliren CE, Graham DA, Zaga C, Morris LL, Bedwell JR, Das P, Zhu H, Lee Y Allen J, Peltz A, Chin K, Schiff BA, Randall DM, Swords C, French D, Ward E, Sweeney JM, Warrillow SJ, Arora A, Narula A, McGrath BA, Cameron TS, Roberson DW. Global Tracheostomy Collaborative: data-driven improvements in patient safety through multidisciplinary teamwork, standardisation, education, and patient partnership. Br J Anaesth. 2020 Jul;125(1):e104-e118. doi: 10.1016/j.bja.2020.04.054. Epub 2020 May 23.

    PubMed 32456776

Questions about this trial

What is this clinical trial studying?

An observational study of Tracheostomy Patients and Multidisciplinary Care Team, run by Vitaz at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 10 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lisa Christiaens, MSc (+3237606060, brecht.serraes@vitaz.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Tracheo(s)tomy-related ICU readmission (time frame: through study completion, an average of 1 year). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07755969, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in